IMG_Mar292021at100626AM.jpg
IVDQiagen’s COVID-19 Testing Arsenal Grows with EUA of NeuMoDx AssayQiagen’s COVID-19 Testing Arsenal Grows with EUA of NeuMoDx Assay
Hilden, Germany-based Qiagen inherited the test when it acquired the remaining stake in NeuMoDx Molecular for $248 million in 2020. The NeuMoDx assay's Emergency Use Authorization comes at a time when developments in COVID-19-related tests are moving at a rapid pace.
Sign up for the QMED & MD+DI Daily newsletter.